Morgan Stanley
FURX

Morgan Stanley’s FURIEX PHARMACEUTICALS INC COM STK (DE) FURX Stock Holding History

Morgan Stanley’s Portfolio FURX Stock Details FURX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		– Sell
-672,384
Closed -$71.4M – 6897
2014
Q2 		$71.4M Buy
672,384
+483,594
+256% +$47.4M 0.03% 628
2014
Q1 		$16.4M Buy
188,790
+172,198
+1,038% +$13.3M 0.01% 1536
2013
Q4 		$697K Sell
16,592
-1,590
-9% -$65.4K ﹤0.01% 4223
2013
Q3 		$800K Sell
18,182
-13,620
-43% -$564K ﹤0.01% 3982
2013
Q2 		$1.08M Buy
+31,802
New +$1.12M ﹤0.01% 3668

Morgan Stanley's FURX Position: Q3 2014 in Review

Morgan Stanley sold out of FURIEX PHARMACEUTICALS INC COM STK (DE) (FURX) in Q3 2014, closing a stake of 672,384 shares — an estimated $71.4M sold.

Morgan Stanley first reported a position in FURX in Q2 2013 and held it in 5 quarters. The position peaked at $71.4M in Q2 2014. 0 funds tracked by Wall St. Rank hold FURX as of Q3 2014.

  • Morgan Stanley reported no remaining FURIEX PHARMACEUTICALS INC COM STK (DE) position as of Q3 2014 after selling out during the quarter.
  • Morgan Stanley sold 672,384 FURIEX PHARMACEUTICALS INC COM STK (DE) shares in Q3 2014, an estimated $71.4M.
  • Morgan Stanley first reported a position in FURIEX PHARMACEUTICALS INC COM STK (DE) in Q2 2013 and held it in 5 quarters.
  • Morgan Stanley's FURIEX PHARMACEUTICALS INC COM STK (DE) position peaked at $71.4M in Q2 2014.
  • 0 funds tracked by Wall St. Rank held FURIEX PHARMACEUTICALS INC COM STK (DE) as of Q3 2014.

Based on Morgan Stanley's 13F filing for Q3 2014, filed 14 Nov 2014.